Investigating a new target for treating lupus

HIPK1: a new immunomodulatory target for SLE

NIH-funded research Children's Hosp of Philadelphia · NIH-10893550

This study is looking at how a protein called HIPK1 affects the immune system in people with lupus, with the hope of finding new ways to help manage the disease.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionChildren's Hosp of Philadelphia NIH-funded
Lab location1 site (Philadelphia, United States)
Project IDNIH-10893550 on NIH RePORTER

What this research studies

This research explores the role of the HIPK1 kinase in systemic lupus erythematosus (SLE), a complex autoimmune disease. By examining the 3D structure of the genome in immune cells, the study aims to understand how HIPK1 influences T cell differentiation and antibody responses. Researchers will employ genetic and pharmacologic methods in both human and mouse models to assess the impact of HIPK1 on SLE pathophysiology. The goal is to uncover new immunomodulatory strategies for managing lupus.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with systemic lupus erythematosus.

Not a fit: Patients with other autoimmune diseases not related to SLE may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to innovative treatments that improve the management of systemic lupus erythematosus.

How similar studies have performed: While HIPK1 has been studied in cancer, its role in immunity and SLE is novel and has not been previously explored.

Where this research is happening

Philadelphia, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.